Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | ACP3 | P15309 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL248239 | 0.82 | CYP1A2 (0.58) | CYP1A2CYP2C19CYP2C9ALDH1A1MEN1 | |
| SCHEMBL29354720 | 0.82 | CYP1A2 (0.58) | CYP1A2CYP2C19CYP2C9ALDH1A1MEN1 | |
| SCHEMBL736614 | 0.82 | DPP4 (0.46) | ALDH1A1MEN1KMT2AL3MBTL1TDP1 | |
| SCHEMBL477544 | 0.81 | PDCD1 (0.47) | CYP1A2CYP2C19CYP2C9ALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL6011728 | 0.80 | CYP1A2 (0.56) | CYP1A2CYP2C19CYP2C9ALDH1A1MEN1 | |
| SCHEMBL7275960 | 0.80 | CYP1A2 (0.56) | CYP1A2CYP2C19CYP2C9ALDH1A1MEN1 | |
| Ammonia Solution, Strong SCHEMBL5431159 | 0.80 | CYP1A2 (0.56) | CYP1A2CYP2C19CYP2C9ALDH1A1MEN1 | |
| SCHEMBL10896807 | 0.79 | DPP4 (0.44) | ALDH1A1MEN1MAPTKMT2AL3MBTL1 | |
| SCHEMBL3101185 | 0.79 | CYP1A2 (0.45) | CYP1A2CYP2C19CYP2C9ALDH1A1MEN1 | |
| SCHEMBL2992860 | 0.79 | MEN1 (0.49) | CYP1A2CYP2C19CYP2C9ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116836062-B | Preparation method of N, N-dimethyl-1-naphthylamine compound | 大连理工大学 | 2025-04-25 | — | — | CN | disclosed |
| CN-116874438-A | One-pot method for preparing polysubstituted 1,2, 3-triazole compound | 大连理工大学 | 2023-10-13 | — | — | CN | disclosed |
| CN-116836062-A | Efficient preparation method of N, N-dimethyl-1-naphthylamine compound | 大连理工大学 | 2023-10-03 | — | — | CN | disclosed |
| CN-101611008-A | C3A receptor modulators and methods of use thereof | ENCYSIVE PHARMACEUTICALS INC (US) | 2009-12-23 | — | — | CN | disclosed |
| EP-2125739-A1 | MODULATORS OF C3A RECEPTOR AND METHODS OF USE THEREOF | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2009-12-02 | — | — | EP | disclosed |
| US-20080188528-A1 | Modulators of C3a receptor and methods of use thereof | ENCYSIVE PHARMACEUTICALS, INC. | 2008-08-07 | — | — | US | disclosed |
| WO-2008079371-A1 | MODULATORS OF C3A RECEPTOR AND METHODS OF USE THEREOF | ENCYSIVE PHARMACEUTICALS, INC. (US) | 2008-07-03 | — | — | WO | disclosed |
| US-6271385-B1 | FUNGICIDES (SUCH AS THOSE FOR USE IN FARMING AND HORTICULTURE). | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2001-08-07 | — | — | US | disclosed |
| EP-1020441-A1 | N-HETEROCYCLIC METHYLPROPYLAMINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND GERMICIDES | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2000-07-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080188528-A1 | Modulators of C3a receptor and methods of use thereof | C3AR1, C5, C5AR1 | CYP1A2 1513/4885CYP2C19 1449/4885CYP2C9 3080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.